ONPH is exploring strategic partnerships and opportunities in oncology
Our Portfolio (Licences - LOI)
Nanosmart Pharmaceuticals -
NanoSmart's® platform technology (US Patent No: 7,799,327 and EU 1706145 B1)
Connect2Med
Social engagement and retention platform for clinical trials
Licences
